Application no. and date | 17708104.9 (espacenet) (Federated) (European Patent Register), 20170217 | Patent/reg. no. and date | DK/EP 3416654, 20211027 | Publication date | 20181226 | Priority no. and date | US 201662296665 P, 20160218, US 201662428721 P, 20161201 | EP pub. no. and date |
EP 3416654 20181226 | Effective date | | Applicant/owner | Invirsa, Inc., 1275 Kinnear Road
Columbus OH 43212, US | Applicant ref. no. | P78480DK01 | Inventor | SHALWITZ, Robert, 2549 Bryden Road
Bexley OH 43209, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/522 (2006.01) , A61K 31/675 (2006.01) , A61K 31/7076 (2006.01) , A61K 33/24 (2019.01) , A61K 45/06 (2006.01) , A61P 11/00 (2006.01) , A61P 27/02 (2006.01) , A61P 29/00 (2006.01) , A61P 31/20 (2006.01) , A61P 35/00 (2006.01) , C07H 19/20 (2006.01) | Title | MEDICINSK ANVENDELSE AF 5'-ADENOSINDIPHOSPHATRIBOSE (ADPR) | Int. application no. | US2017018253 | Int. publication no. | WO2017143113 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|